SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity

Chantal B.F. Vogels, Anne E. Watkins, Christina A. Harden, Doug E. Brackney, Jared Shafer, Jianhui Wang, César Caraballo, Chaney C. Kalinich, Isabel M. Ott, Joseph R. Fauver, Eriko Kudo, Peiwen Lu, Arvind Venkataraman, Maria Tokuyama, Adam J. Moore, M. Catherine Muenker, Arnau Casanovas-Massana, John Fournier, Santos Bermejo, Melissa Campbell, Rupak Datta, Allison Nelson, Yale IMPACT Research Team, Charles S. Dela Cruz, Albert I. Ko, Akiko Iwasaki, Harlan M. Krumholz, JD Matheus, Pei Hui, Chen Liu, Shelli F. Farhadian, Robby Sikka, Anne L. Wyllie, Nathan D. Grubaugh
doi: https://doi.org/10.1101/2020.08.03.20167791

Article Information

doi 
https://doi.org/10.1101/2020.08.03.20167791
History 
  • September 28, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Chantal B.F. Vogels1,†,*,
  2. Anne E. Watkins1,†,
  3. Christina A. Harden1,†,
  4. Doug E. Brackney2,†,
  5. Jared Shafer3,
  6. Jianhui Wang4,
  7. César Caraballo5,6,
  8. Chaney C. Kalinich1,
  9. Isabel M. Ott1,
  10. Joseph R. Fauver1,
  11. Eriko Kudo7,
  12. Peiwen Lu7,
  13. Arvind Venkataraman7,
  14. Maria Tokuyama7,
  15. Adam J. Moore1,
  16. M. Catherine Muenker1,
  17. Arnau Casanovas-Massana1,
  18. John Fournier8,
  19. Santos Bermejo9,
  20. Melissa Campbell8,
  21. Rupak Datta8,
  22. Allison Nelson8,
  23. Yale IMPACT Research Team,
  24. Charles S. Dela Cruz9,
  25. Albert I. Ko1,
  26. Akiko Iwasaki7,
  27. Harlan M. Krumholz5,6,
  28. JD Matheus3,
  29. Pei Hui4,
  30. Chen Liu4,
  31. Shelli F. Farhadian8,
  32. Robby Sikka10,
  33. Anne L. Wyllie1,#,* and
  34. Nathan D. Grubaugh1,#,*
  1. 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA
  2. 2Connecticut Agricultural Experimental Station, State of Connecticut, New Haven, CT, 06511 USA
  3. 3Drug Free Sport International, Kansas City, MO 64108, USA
  4. 4Department of Pathology, Yale University School of Medicine, New Haven, CT, 06510, USA
  5. 5Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, 06510, USA
  6. 6Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, 06510, USA
  7. 7Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06510, USA
  8. 8Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA
  9. 9Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06510, USA
  10. 10Minnesota Timberwolves, Minneapolis, MN, 55403 USA
  1. ↵* Correspondence: Chantal B.F. Vogels (chantal.vogels{at}yale.edu), Anne L. Wyllie (anne.wyllie{at}yale.edu), Nathan D. Grubaugh (nathan.grubaugh{at}yale.edu)

  1. ↵† These authors contributed equally

  2. ↵# Senior authors

Back to top
Posted September 28, 2020.
Download PDF
Data/Code
Email
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
Chantal B.F. Vogels, Anne E. Watkins, Christina A. Harden, Doug E. Brackney, Jared Shafer, Jianhui Wang, César Caraballo, Chaney C. Kalinich, Isabel M. Ott, Joseph R. Fauver, Eriko Kudo, Peiwen Lu, Arvind Venkataraman, Maria Tokuyama, Adam J. Moore, M. Catherine Muenker, Arnau Casanovas-Massana, John Fournier, Santos Bermejo, Melissa Campbell, Rupak Datta, Allison Nelson, Yale IMPACT Research Team, Charles S. Dela Cruz, Albert I. Ko, Akiko Iwasaki, Harlan M. Krumholz, JD Matheus, Pei Hui, Chen Liu, Shelli F. Farhadian, Robby Sikka, Anne L. Wyllie, Nathan D. Grubaugh
medRxiv 2020.08.03.20167791; doi: https://doi.org/10.1101/2020.08.03.20167791
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area